Adding Farxiga (dapagliflozin) to standard care significantly reduced the risk of death or worsening heart failure in older ...

The prognosis of severe diastolic heart failure is similar to that of systolic heart failure ... are used in selected patients to decrease left ventricular hypertrophy. To decrease myocardial ...

The following is a summary of "Novel Right Ventricular Function Parameters Can Identify Short-Term Non-Responders To ...

The role of ACE inhibitors in the management of HFPEF is less significant compared with their role in the management of heart failure with left ventricular systolic dysfunction. For patients with ...

Vascular endothelial growth factor inhibitors (VEGFIs) have transformed treatment paradigms for several malignancies. By ...

TAVR was associated with similar and stable valve hemodynamics and improved hemodynamic burden on both left and right ventricular function at five years compared with SAVR in low-risk patients with ...

The growing morbidity, mortality, and health care costs related to heart failure (HF) underscore the urgent need to ...

People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful ...

When considering whether a child who has a single-ventricle heart defect would benefit more from biventricular repair or the ...

People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful valve surgery. The condition is more common in women and younger patients ...

People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful valve surgery.

PRINCETON, N.J., April 14, 2025--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the treatment of adult patients ...